FDA: Class I recall of HeartStart MRx Defibrillator
Editor's Note
The Food & Drug Administration (FDA) on February 9 classified the recall by Philips Electronics (Andover, Massachusetts) of its HeartStart MRx Defibrillator as Class I, the most serious.
The recall was initiated because of micro cracks in the gas discharge tube that allow internal gasses to escape and can cause the tube to malfunction.
The defects may also permit an electrical current surge to cross the device’s designated resistors, which will damage the resistors and prevent the device from working in automated external defibrillator mode. As a result, the defibrillator may fail at any time, including when delivering repeated shocks to patients.
Posted 02/09/2018] AUDIENCE: Emergency Medicine, Risk Manager, Nursing ISSUE: Philips is recalling the HeartStart MRx Defibrillator due to a defect in the device's Gas Discharge Tube (GDT). The GDT has micro cracks which allows internal gasses to escape and causes the tubes to not function as expected.
Free Daily News
- Study: COVID-19's impact on oncological surgery offers lessons for future crises
- Study links pandemic stress to persistent increases in nursing-sensitive quality indicators
- Save the date for the 2025 OR Business Management Conference
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO